XXIIConsumer Defensive · Tobacco

XXII Stock Forecast: 22nd Century Group, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026

$0.91

+7.78% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 14 of 100 as at 3 Oct 2026 — in the weakest quartile.

Market cap

$652,590.00

Ticker Nerd rank

14 / 100

Median analyst target

—

Analysts covering

Revenue$1.3M−40.4% y/y

Operating income−$3.3M

Net income−$3.3M

Free cash flow−$4.3M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−31.3%

−60.9%

YTD

−99.6%

−99.8%

From 52W high

−99.8%

From 52W low

+14.0%

$504

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

XXII stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores 22nd Century Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026

14 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

100

Accruals

Issuance

Growth

Revisions

Quality

Volatility

Momentum

Value

Size (100): Smaller than most of the companies we track.

Value (0): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

XXII stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on XXII, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
23 Aug 2023	Roth MKM	Reiterates	Buy	$5.00
17 Aug 2023	Alliance Global Partners	Downgrade	Neutral	—
15 Aug 2023	Dawson James	Maintains	Buy	—
15 Aug 2023	TD Cowen	Downgrade	Market Perform	—
3 July 2023	Dawson James	Maintains	Buy	—
9 Nov 2022	Alliance Global Partners	Maintains	Buy	$5.00 → $4.00
21 July 2022	Alliance Global Partners	Initiates	Buy	$5.00
15 June 2022	Craig-Hallum	Initiates	Buy	—
8 Mar 2022	Roth Capital	Initiates	Buy	—
4 Mar 2022	Dawson James	Maintains	Buy	—
24 Feb 2022	Dawson James	Maintains	Buy	—
16 Feb 2022	Dawson James	Maintains	Buy	—
24 Jan 2022	Dawson James	Maintains	Buy	—
6 Jan 2022	Dawson James	Maintains	Buy	—
23 July 2021	Cowen & Co.	Initiates	Outperform	—
26 Jan 2018	Chardan Capital	Maintains	Buy	$12

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XXII appears on the weeks it earns a place.

Performance

XXII vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, 22nd Century Group, Inc. returned −99.8% against +16.2% for the S&P 500, dividends included.

XXII vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

XXII analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

22nd Century Group, Inc. (XXII) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 0.0×
Price / sales: 0.1×
Price / book: 0.0×
EV / EBITDA: 0.3×

Growth & margins

Revenue growth (YoY): −40.4%
Earnings growth (YoY): −40.4%
Gross margin: −22.1%
Operating margin: −247.8%
Net margin: −76.0%

Returns & dividend

Return on equity: −105.7%
Return on assets: −30.9%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

22nd Century Group, Inc. (XXII) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

22nd Century Group, Inc. has a market value of $653K and an enterprise value of −$3.7M.
Revenue in the twelve months to 30 June 2026: $5.2M. The latest quarter shrank 40.4% year on year.
Net income over the same four quarters: −$3.9M, a −76.0% net margin.
Free cash flow in the twelve months to 30 June 2026: −$9.5M.
Shares outstanding: 502,839.
Trailing P/E: 0.0×; forward P/E: −0.1× — the forward figure prices analyst consensus estimates, not reported earnings.
22nd Century Group, Inc. employs 32 people — $161K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Oct 2026

Data provided by Twelve Data

Peers

XXII vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelTobacco

Company	Market cap	TKN rank
XXII22nd Century Group, Inc.	$652,590.00	14
GNLNGreenlane Holdings, Inc.	$1.8M	19
RKDAArcadia Biosciences, Inc.*	$694,300.00	32
EDVAEndovia Health Sciences, Inc.*	$1.0M	3
FCHLFitness Champs Holdings Ltd.*	$1.2M	13
MSSMaison Solutions, Inc.*	$1.4M	37
BIOTInstinct Bio Technical Co. Holdings, Inc.*	$1.5M	18

* Nearest Consumer Defensive names by size — few tobacco companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own 22nd Century Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest XXII news & analysis

22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative

GlobeNewsWire · 28 Sept 2026positive

French health agency ANSES has recommended a maximum nicotine limit for all combustible tobacco products. 22nd Century Group noted that its supply now includes non-GMO reduced-nicotine tobacco, which addresses a key feasibility question for France and the EU around such a limit.

Why it matters — A nicotine cap in France or the EU could create demand for reduced-nicotine tobacco, aligning with 22nd Century's product platform.

22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule

GlobeNewsWire · 24 Sept 2026neutral

22nd Century Group issued a statement urging policymakers, including HHS Secretary Kennedy, Acting FDA Commissioner Diamantas, and CTP Director Koplow, to enact and implement the Reduced Nicotine Content Standard, noting that years have passed without a final rule on the matter.

Why it matters — A watcher of 22nd Century Group would care because the company is publicly pressing regulators on a policy it has long advocated for, signaling its continued focus on reduced-nicotine products.

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

GlobeNewsWire · 1 Sept 2026positive

22nd Century Group's CEO and Chairman Lawrence Firestone issued a mid-year stockholder letter highlighting improved gross margin, distribution to approximately 5,000 retail outlets, and what the company describes as a greater than $50 billion market opportunity. The letter also cites rising same-store sales and an accelerated commercial execution phase for the second half of 2026.

Why it matters — A XXII watcher would care because the letter provides management's assessment of the company's commercial progress and outlook for its low-nicotine product category.

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026

GlobeNewsWire · 18 Aug 2026neutral

22nd Century Group announced it will participate in the HC Wainwright Conference on September 15, 2026, at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative.

Why it matters — The conference participation offers investors an opportunity to meet with 22nd Century Group's management, which could raise visibility and engagement with the investment community.

22nd Century Group, Inc. (XXII) Q2 2026 Earnings Call Prepared Remarks Transcript

Seeking Alpha · 13 Aug 2026neutral

22nd Century Group, Inc. held its Q2 2026 earnings call, and a transcript of the prepared remarks was published on Seeking Alpha. The transcript covers the company's second-quarter 2026 financial results and management commentary.

Why it matters — A XXII watcher would care because the earnings call transcript provides direct insight into the company's quarterly performance and management's outlook.

FAQ

Frequently asked questions about XXII stock

How does Ticker Nerd's model rank XXII?

As at 3 Oct 2026, 22nd Century Group, Inc. ranks 14 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (100 of 100).

What is the XXII stock forecast for 2030?

No analyst covering 22nd Century Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XXII are extrapolating price history, which says nothing about the business.

How has XXII stock performed over the past year?

22nd Century Group, Inc. returned -99.8% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does 22nd Century Group, Inc. do?

22nd Century Group Inc. is a tobacco products and plant biotechnology company focused on reduced nicotine tobacco solutions and related plant science applications.

What is the latest news on XXII?

The most recent item we track (GlobeNewsWire, 28 Sept 2026): "22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative". French health agency ANSES has recommended a maximum nicotine limit for all combustible tobacco products. 22nd Century Group noted that its supply now includes non-GMO reduced-nicotine tobacco, which addresses a key feasibility question for France and the EU around such a limit.

Company

About 22nd Century Group, Inc.

22nd Century Group Inc. is a tobacco products and plant biotechnology company focused on reduced nicotine tobacco solutions and related plant science applications. The company develops and commercializes proprietary tobacco products designed to lower nicotine content, including very low nicotine cigarettes, branded filtered cigars, and other combustible tobacco offerings. It also provides contract manufacturing services for third-party tobacco brands, supporting conventional cigarettes and filtered cigars through turnkey production capabilities. In addition to its tobacco segment, 22nd Century Group works with hemp and cannabis-related plant technologies, applying genetic engineering, gene-editing, and modern breeding methods to modify plant characteristics. Headquartered in Mocksville, North Carolina, 22nd Century Group serves the consumer goods, life sciences, and agricultural biotechnology markets, where it plays a specialized role in tobacco harm reduction and plant-based product development.

CEO Mr. Lawrence D. Firestone · 32 employees · United States · https://www.xxiicentury.com